HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased turnover of the CNS myelin protein Opalin in a mouse model of hereditary spastic paraplegia 35.

Abstract
Spastic paraplegia 35 (SPG35) (OMIM: 612319) or fatty acid hydroxylase-associated neurodegeneration (FAHN) is caused by deficiency of fatty acid 2-hydroxylase (FA2H). This enzyme synthesizes sphingolipids containing 2-hydroxylated fatty acids, which are particularly abundant in myelin. Fa2h-deficient (Fa2h-/-) mice develop symptoms reminiscent of the human disease and therefore serve as animal model of SPG35. In order to understand further the pathogenesis of SPG35, we compared the proteome of purified CNS myelin isolated from wild type and Fa2h-/- mice at different time points of disease progression using tandem mass tag labeling. Data analysis with a focus on myelin membrane proteins revealed a significant increase of the oligodendrocytic myelin paranodal and inner loop protein (Opalin) in Fa2h-/- mice, whereas the concentration of other major myelin proteins was not significantly changed. Western blot analysis revealed an almost 6-fold increase of Opalin in myelin of Fa2h-/- mice aged 21-23 months. A concurrent unaltered Opalin gene expression suggested a decreased turnover of the Opalin protein in Fa2h-/- mice. Supporting this hypothesis, Opalin protein half-life was reduced significantly when expressed in CHO cells synthesizing 2-hydroxylated sulfatide, compared to cells synthesizing only non-hydroxylated sulfatide. Degradation of Opalin was inhibited by inhibitors of lysosomal degradation but unaffected by proteasome inhibitors. Taken together, these results reveal a new function of 2-hydroxylated sphingolipids namely affecting the turnover of a myelin membrane protein. This may play a role in the pathogenesis of SPG35.
AuthorsRobert Hardt, Silvia Jordans, Dominic Winter, Volkmar Gieselmann, Lihua Wang-Eckhardt, Matthias Eckhardt
JournalHuman molecular genetics (Hum Mol Genet) Vol. 29 Issue 22 Pg. 3616-3630 (01 21 2021) ISSN: 1460-2083 [Electronic] England
PMID33215680 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Myelin Proteins
  • Opalin protein, mouse
  • Sphingolipids
  • Amidohydrolases
  • fatty-acid amide hydrolase
Topics
  • Amidohydrolases (genetics)
  • Animals
  • Disease Models, Animal
  • Gene Expression Regulation (genetics)
  • Heredodegenerative Disorders, Nervous System (genetics, metabolism, pathology)
  • Humans
  • Mice
  • Myelin Proteins (genetics)
  • Myelin Sheath (genetics, metabolism)
  • Oligodendroglia (metabolism)
  • Pedigree
  • Spastic Paraplegia, Hereditary (genetics, metabolism, pathology)
  • Sphingolipids (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: